In last trading session, BriaCell Therapeutics Corp (NASDAQ:BCTX) saw 1.13 million shares changing hands with its beta currently measuring 1.38. Company’s recent per share price level of $0.84 trading at $0.09 or 12.74% at ring of the bell on the day assigns it a market valuation of $30.47M. That closing price of BCTX’s stock is at a discount of -610.71% from its 52-week high price of $5.97 and is indicating a premium of 45.24% from its 52-week low price of $0.46. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.16 million shares which gives us an average trading volume of 5.02 million if we extend that period to 3-months.
BriaCell Therapeutics Corp (NASDAQ:BCTX) trade information
Upright in the green during last session for gaining 12.74%, in the last five days BCTX remained trading in the green while hitting it’s week-highest on Wednesday, 11/27/24 when the stock touched $0.84 price level, adding 0.27% to its value on the day. BriaCell Therapeutics Corp’s shares saw a change of -85.60% in year-to-date performance and have moved 39.85% in past 5-day. BriaCell Therapeutics Corp (NASDAQ:BCTX) showed a performance of 1.20% in past 30-days. Number of shares sold short was 0.53 million shares which calculate 0.56 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BriaCell Therapeutics Corp (BCTX) estimates and forecasts
Statistics highlight that BriaCell Therapeutics Corp is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -47.03% of value to its shares in past 6 months, showing an annual growth rate of -100.00% while that of industry is 17.70. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 47.85% during past 5 years.
